Lexaria Bioscience Corp. (LEXX) vs Lunai Bioworks Inc. (LNAI)

A side-by-side comparison of Lexaria Bioscience Corp. and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LEXX

Lexaria Bioscience Corp.

$5M

$2.89HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

LNAI

Lunai Bioworks Inc.

$5M

$1.16HealthcareDelayed quote: Oct 6, 2026, 12:43 PM EDT

Total return — LEXX vs LNAI

growth of $100 · dividends reinvested · last 1y

LEXX -79.2% (-79.2%/yr)LNAI -93.8% (-93.8%/yr)LEXX compounded faster over this window

LEXX LNAI

LEXX vs LNAI: by the numbers

•LNAI is the larger company ($5M vs $5M market cap).
•Both run net losses; LEXX's is the smaller (-3985.58% vs -612568.11% net margin).

Metrics side by side

Valuation

Metric	LEXX	LNAI
P/S ratio	24.62	251.14
P/B ratio	1.01	N/A

Profitability

Metric	LEXX	LNAI
Gross margin	100.00%	0.00%
Operating margin	-1683.01%	0.00%
Net margin	-3985.58%	-612568.11%
ROE	-163.18%	N/A
ROIC	-175.26%	N/A

Growth (annualized)

Metric	LEXX	LNAI
Revenue CAGR (5Y)	12.92%	N/A
Total return CAGR (5Y)	-50.86%	N/A

Go deeper

Full LEXX analysis Full LNAI analysis Interactive comparison tool

Dig into the metrics

Lexaria Bioscience ROE Lunai Bioworks ROE Lexaria Bioscience operating margin Lunai Bioworks operating margin Lexaria Bioscience revenue growth Lunai Bioworks revenue growth Lexaria Bioscience free cash flow Lunai Bioworks free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.